Atlas Trials

A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)

Clinical trial NCT03864614 · COMPLETED

Trial details

NCT number
NCT03864614
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2019-02-27
Primary completion
2023-06-22
Enrollment
1515

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.